Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Endocrinology (1994) 134(5):204450.10.1210/endo.134.5.7512496 236 FichterMMPirkeKMHolsboerF
Specification General characteristics UNITED STATES Country of origin UNITED STATES Bcuelov Brand Bcuelov Article number 00043626
Wipe the area thoroughly with an alcohol swab before injecting to remove cream residue and prevent contamination
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently under clinical development for obesity and type 2 diabetes
Experimental Design of in vitro and in vivo Studies To investigate the effect of IGF-1 on IL-1-induced chondrocytes, cells were plated in a 6-well plate at a density of 510 6 cells/well
US$ 26.89
US$ 28.10
US$ 25.15
US$ 28.79
US$ 22.61
US$ 22.18
US$ 26.25
US$ 23.85
